Imbrium Therapeutics Announces FDA Orphan Drug Designation for Tinostamustine for the Treatment of…
Imbrium Therapeutics L.P., a clinical-stage biopharmaceutical company and operating subsidiary of Purdue Pharma L.P., in conjunction with Mundipharma EDO GmbH, announced that the U.S.…
Read More...
Read More...
